Compounds > arsenic
Page last updated: 2024-08-26

arsenic and Lymphoma

arsenic has been researched along with Lymphoma in 44 studies

Research

Studies (44)

TimeframeStudies, this research(%)All Research%
pre-199015 (34.09)18.7374
1990's6 (13.64)18.2507
2000's16 (36.36)29.6817
2010's6 (13.64)24.3611
2020's1 (2.27)2.80

Authors

AuthorsStudies
Ahn, RW; Avram, MJ; Bally, MB; Barrett, SL; Chen, H; Gordon, LI; Jozefik, JK; Mazar, AP; O'Halloran, TV; Raja, MR; Shea, LD; Spaho, L; Winter, JN; Woodruff, TK1
Hong, L; Kong, D; Qiao, Z; Shi, W; Sun, G; Zhang, Y; Zhao, H; Zhao, M1
Bashford, J; Bradstock, K; Browett, P; Campbell, LJ; Catalano, A; Collins, M; Di Iulio, J; Filshie, R; Firkin, F; Grigg, A; Hertzberg, M; Hugman, A; Iland, HJ; Moore, J; Reynolds, J; Seldon, M; Seymour, JF; Supple, SG; Szer, J; Taper, J; Taylor, K; Tiley, C1
Ahuja, HG; Bailey, HH; Chang, JE; Kahl, BS; Kim, K; Kolesar, JM; Rodriguez, GA; Sanchez, FA; Voorhees, PM; Werndli, J1
Li, HM; Long, Y; Qing, C; Yu, MJ; Zhang, YL1
Huang, R; Huang, X; Li, W; Li, X; Yang, X1
Du, XY; Li, Y; Liu, XJ; Luo, JM; Wen, SP; Yang, L1
Dong, ZR; Du, XY; Li, Y; Liu, XJ; Luo, JM; Wen, SP; Yang, JC; Yang, L; Yao, L1
Bhalla, S; David, K; Evens, AM; Gordon, LI; Guo, D; O'Halloran, T; Platanias, LC; Prachand, S; Singh, AT; Winter, JN; Yang, S1
Fan, LP; Fu, HY; Shen, JZ; Shen, SF; Zhou, HR1
Gabrilove, J; Jing, Y; Liu, C; Wang, R; Waxman, S; Xia, L; Zhao, G1
Amiot, L; Bernard, M; Drenou, B; Fardel, O; Fauchet, R; Lamy, T; Le Meur, A; Le Thiec, A; Lecureur, V1
Chen, GQ; Chen, Z; Jing, Y; Styblo, M; Walton, F; Waxman, S; Weinberg, R; Zhou, L1
KIDD, JG1
DELAMATER, ED; ROOSA, RA1
Chen, Z; Jing, Y; Styblo, M; Waxman, S; Zhou, L1
Chen, SJ; Chen, Z; Dong, Y; Fang, J; Hu, J1
Chan, R; Chen, D; Jing, Y; Waxman, S1
Abou-Merhi, R; Arnoult, D; Bazarbachi, A; Dbouk, H; de Thé, H; El Hajj, H; El-Sabban, ME; Gessain, A; Hermine, O; Khoriaty, R; Mahieux, R; Munier, S1
Bismar, TA; Diaz, Z; Laurenzana, A; Mann, KK; Miller, WH; Schipper, HM1
Adamson, PC; Balis, FM; Blaney, SM; Fox, E; Goodspeed, W; Murgo, AJ; O'Brien, M; Razzouk, BI; Reaman, GH; Widemann, BC; Xiao, S1
Li, HM; Li, LH1
Galt, RM; Knock, FE; Oester, YT1
Adami, HO; Dich, J; Hanberg, A; Zahm, SH1
Dai, J; Jing, Y; Waxman, S; Weinberg, RS1
Cai, X; Chen, GQ; Chen, SJ; Chen, Z; Dai, J; Huang, Y; Jia, PM; Jing, YK; Shen, YL; Shi, GY; Sun, YP; Tang, W; Wang, ZY; Waxman, S; Zhang, TD; Zhu, XH1
Cheson, BD; McBee, WL; Murgo, AJ1
Nie, L; Zhang, Y1
Cai, X; Chen, G; Shen, Y1
Levine, L1
Li, CW; Li, RL; Li, YS; Ma, YY; Tan, W; Wei, ZR; Zhang, TD; Zhao, XL1
Cheng, YY; Guo, HR; Li, CY; Lin, MH1
ARNAUD, G; BOUCHER, H; LIAUME, P1
MALLET, L1
DUHAMEL, G; MALLET, L; MARCHAL, G1
HEITE, HJ1
Grünwald, HW; Rosner, F1
Hisanaga, A; Inamasu, T; Ishinishi, N; Mizunoe, M1
Doerr, CL; Harrington-Brock, K; Moore, MM1
Blejer, HP; Wagner, W1
Anson, JF; Burns, ER; Casciano, DA; Hinson, WG; Pipkin, JL2
Anson, JF; Burns, ER; Casciano, DA; Hinson, WG; Pipkin, JL; Sheehan, DM1
Goerttler, K; Osswald, H1

Reviews

4 review(s) available for arsenic and Lymphoma

ArticleYear
Arsenic in cancer therapy.
    Anti-cancer drugs, 2005, Volume: 16, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenicals; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Leukemia; Lymphoma; Multiple Myeloma

2005
[Progression of foundational and clinical studies on use of arsenic trioxide in treatment of lymphoma--review].
    Zhongguo shi yan xue ye xue za zhi, 2007, Volume: 15, Issue:6

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Humans; Lymphoma; Oxides

2007
Pesticides and cancer.
    Cancer causes & control : CCC, 1997, Volume: 8, Issue:3

    Topics: Animals; Arsenicals; Breast Neoplasms; Carcinogens; Causality; Chlordan; Creosote; DDT; Ditiocarb; Female; Herbicides; Hexachlorocyclohexane; Humans; Insecticides; Leukemia; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Mutagens; Neoplasms; Neoplasms, Experimental; Occupational Diseases; Occupational Exposure; Ovarian Neoplasms; Pesticides; Phenols; Protective Devices; Sarcoma; Triazines

1997
Cytotoxic drugs and leukaemogenesis.
    Clinics in haematology, 1980, Volume: 9, Issue:3

    Topics: Adult; Aged; Arsenic; Benzene; Bone Marrow; Breast Neoplasms; Female; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Mycosis Fungoides; Ovarian Neoplasms; Paraproteinemias; Waldenstrom Macroglobulinemia

1980

Trials

4 trial(s) available for arsenic and Lymphoma

ArticleYear
A phase II study of arsenic trioxide in patients with relapsed or refractory malignant lymphoma.
    Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Lymphoma; Male; Middle Aged; Oxides; Recurrence; Treatment Outcome

2015
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.
    The Lancet. Haematology, 2015, Volume: 2, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Australia; Consolidation Chemotherapy; Female; Humans; Leukemia, Promyelocytic, Acute; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Oxides; Remission Induction; Treatment Outcome; Young Adult

2015
Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study.
    Hematological oncology, 2009, Volume: 27, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Female; Glutathione; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Oxides; Safety

2009
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma.
    Blood, 2008, Jan-15, Volume: 111, Issue:2

    Topics: Abdominal Pain; Adolescent; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Child; Child, Preschool; Constipation; Dermatitis; Dose-Response Relationship, Drug; Female; Headache; Humans; Hyperglycemia; Infusions, Intravenous; Leukemia, Promyelocytic, Acute; Lymphoma; Male; Nausea; Oxides; Pancreatitis; Pneumonia; Recurrence; Time Factors; Vomiting; Water-Electrolyte Balance

2008

Other Studies

36 other study(ies) available for arsenic and Lymphoma

ArticleYear
Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivo.
    PloS one, 2013, Volume: 8, Issue:3

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Female; Fertility; Humans; Lymphoma; Mice; Nanocapsules; Ovarian Follicle; Ovary; Oxides; Xenograft Model Antitumor Assays

2013
[Apoptosis and cell cycle arrest in lymphoma Raji cells induced by arsenic trioxide].
    Zhongguo shi yan xue ye xue za zhi, 2008, Volume: 16, Issue:6

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Humans; Lymphoma; Oxides

2008
[Effect of arsenic trioxide combined with adriamycin on the proliferation and apoptosis of human lymphoma cells].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2009, Volume: 34, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Synergism; Humans; Lymphoma; Oxides

2009
[Effect of As2O3 on demethylation of SHP-1 gene in human lymphoma cell line T2].
    Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; DNA Methylation; Dose-Response Relationship, Drug; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Lymphoma; Oxides; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Proto-Oncogene Proteins c-kit; RNA, Messenger; Signal Transduction

2009
[As2O3 induces demethylation and up-regulates transcription of SHP-1 gene in human lymphoma cell line T2 cells].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2009, Volume: 31, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; CpG Islands; DNA Methylation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Oxides; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Proto-Oncogene Proteins c-kit; RNA, Messenger; Transcriptional Activation; Up-Regulation

2009
Glutathione depletion enhances arsenic trioxide-induced apoptosis in lymphoma cells through mitochondrial-independent mechanisms.
    British journal of haematology, 2010, Volume: 150, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Glutathione; Humans; Lymphoma; Mitochondria; Oxides

2010
[Arsenic trioxide reverses hypermethylation of p16 and activates its transcription in malignant lymphoma cell line CA46].
    Zhongguo shi yan xue ye xue za zhi, 2010, Volume: 18, Issue:2

    Topics: Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p16; DNA Methylation; Genes, p16; Humans; Lymphoma; Oxides; Transcriptional Activation

2010
Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Dec-15, Volume: 18, Issue:24

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspases; Catalase; Cell Line, Tumor; Drug Synergism; Enzyme Activation; Ethacrynic Acid; Glutathione; Glutathione S-Transferase pi; Humans; Leukemia, Myeloid; Lymphoma; MAP Kinase Kinase 4; Membrane Potential, Mitochondrial; Myeloid Cell Leukemia Sequence 1 Protein; Oxides; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Signal Transduction

2012
Potassium antimonyl tartrate induces caspase- and reactive oxygen species-dependent apoptosis in lymphoid tumoral cells.
    British journal of haematology, 2002, Volume: 119, Issue:3

    Topics: Amino Acid Chloromethyl Ketones; Antimony Potassium Tartrate; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Caspases; Cell Survival; Coumarins; Cysteine Proteinase Inhibitors; Fluorescent Dyes; Humans; Lymphoma; Oligopeptides; Oxides; Reactive Oxygen Species; Tumor Cells, Cultured

2002
Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells.
    Cancer research, 2003, Apr-15, Volume: 63, Issue:8

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Differentiation; Coculture Techniques; Glutathione Peroxidase; Hematopoietic Stem Cells; Humans; Hydrogen Peroxide; K562 Cells; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Lymphoma; Methylation; Neoplasm Proteins; Oncogene Proteins, Fusion; Oxides; Tumor Cells, Cultured

2003
Effects of arsenic-azoproteins on mouse lymphoma cells in vivo; with observations on the effects of other anti-lymphoma agents, and on the susceptibility to these effects of lymphoma cells of various types.
    The Journal of experimental medicine, 1958, Nov-01, Volume: 108, Issue:5

    Topics: Animals; Antineoplastic Agents; Arsenic; Arsenicals; Fluorouracil; Guinea Pigs; Lymphoma; Mice; Neoplasms, Experimental

1958
A cytological evaluation of combined therapy in the 6C3HED lymphosarcoma. I. -SH-containing analogs in combination with nitrogen mustard and mapharsen.
    Cancer research, 1960, Volume: 20

    Topics: Antineoplastic Agents; Arsenicals; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Organic Chemicals; Sulfhydryl Compounds

1960
Glutathione-S-transferase pi inhibits As2O3-induced apoptosis in lymphoma cells: involvement of hydrogen peroxide catabolism.
    Blood, 2005, Feb-01, Volume: 105, Issue:3

    Topics: Apoptosis; Arsenicals; Cell Survival; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Hydrogen Peroxide; Isoenzymes; Jurkat Cells; Lymphoma

2005
Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors.
    Cancer research, 2006, Dec-01, Volume: 66, Issue:23

    Topics: Amino Acid Chloromethyl Ketones; Anthracenes; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Buthionine Sulfoximine; Caspase 3; Caspase Inhibitors; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Glutathione; Humans; Hydrogen Peroxide; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Leukemia; Lymphoma; Oxides; Receptors, TNF-Related Apoptosis-Inducing Ligand; Time Factors; U937 Cells

2006
PS-341 or a combination of arsenic trioxide and interferon-alpha inhibit growth and induce caspase-dependent apoptosis in KSHV/HHV-8-infected primary effusion lymphoma cells.
    Leukemia, 2007, Volume: 21, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-X Protein; Boronic Acids; Bortezomib; Caspases; Cell Proliferation; Herpesvirus 8, Human; Humans; Interferon-alpha; Lymphoma; Membrane Potential, Mitochondrial; NF-kappa B; Oxides; Protease Inhibitors; Pyrazines

2007
Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicity.
    Leukemia, 2007, Volume: 21, Issue:10

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Chromans; Cytochromes c; Drug Synergism; Humans; Liver; Lymphoma; Membrane Potential, Mitochondrial; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Oxides

2007
Protein-sulfhydryl groups in cellular control mechanisms and cancer.
    Journal of the American Geriatrics Society, 1967, Volume: 15, Issue:10

    Topics: Adenocarcinoma; Adult; Animals; Arsenicals; Carcinoma, Ehrlich Tumor; Carcinoma, Squamous Cell; Choriocarcinoma; DNA, Neoplasm; Female; Fluorides; Heparin; Humans; Lung Neoplasms; Lymphoma; Male; Malonates; Mandibular Neoplasms; Mice; Middle Aged; Neoplasms; Pregnancy; RNA, Neoplasm; Sarcoma; Testicular Neoplasms; Vitamin K

1967
Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.
    Blood, 1999, Jan-01, Volume: 93, Issue:1

    Topics: Acetylcysteine; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Cells, Cultured; Drug Synergism; Glutathione; Growth Inhibitors; Hematopoietic Stem Cells; HL-60 Cells; Humans; Lymphoma; Mice; Mice, Inbred Strains; Oxidation-Reduction; Oxides; Tumor Cells, Cultured

1999
Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
    Journal of the National Cancer Institute, 1999, May-05, Volume: 91, Issue:9

    Topics: Adenosine Triphosphate; Annexin A5; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Caspase 3; Caspases; Cell Division; Down-Regulation; Enzyme Activation; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Lymphocytes; Lymphoma; Mitochondria; Neoplasm Proteins; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins

1999
Clinical trials referral resource. Clinical trials with arsenic trioxide.
    Oncology (Williston Park, N.Y.), 2000, Volume: 14, Issue:2

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Clinical Trials as Topic; Female; Humans; Leukemia; Lymphoma; Multiple Myeloma; Neoplasms; Oxides; Urogenital Neoplasms; Uterine Cervical Neoplasms

2000
Studies of apoptosis of malignant lymphoma cells induced by arsenic trioxide.
    Cell biology international, 2001, Volume: 25, Issue:10

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Division; DNA, Neoplasm; Dose-Response Relationship, Drug; Flow Cytometry; Humans; In Situ Nick-End Labeling; Jurkat Cells; Lymphoma; Oxides; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2001
[Glutathione synthesis inhibitor enhances arsenic trioxide-induced apoptosis].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1999, Volume: 21, Issue:4

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Glutathione; Humans; Leukemia; Lymphoma; Oxides; Tumor Cells, Cultured

1999
Regulation of arachidonic acid metabolism by phenylarsine oxide.
    Biochemical and biophysical research communications, 1991, Jul-31, Volume: 178, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acids; Arsenicals; Bradykinin; Calcimycin; Cell Line; Epoprostenol; Kinetics; Liver; Lymphoma; Mice; Platelet Activating Factor; Rats

1991
[Traditional Chinese and Western medicine in the treatment of 27 patients with malignant lymphoma].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1988, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Animals; Arsenicals; Carcinoma, Ehrlich Tumor; Drug Compounding; Drugs, Chinese Herbal; Female; Humans; Lymphoma; Male; Mercury; Mice; Middle Aged; Sarcoma 180; Sarcoma 37

1988
Arsenic in Drinking Water and Incidences of Leukemia and Lymphoma: Implication for Its Dual Effects in Carcinogenicity.
    Frontiers in public health, 2022, Volume: 10

    Topics: Arsenic; Carcinogenesis; Drinking Water; Female; Hematologic Neoplasms; Humans; Incidence; Leukemia; Lymphoma; Male; Neoplasms

2022
[Generalized lymphoblastic sarcoma during severe occupational poisoning by arsenic].
    Archives des maladies professionnelles de medecine du travail et de securite sociale, 1951, Volume: 12, Issue:1

    Topics: Arsenic; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Occupational Health; Sarcoma

1951
[Use of arsenic 76, the radioactive isotope, in the treatment of certain malignant skin diseases].
    Journal de radiologie, d'electrologie & archives d'electricite medicale, 1951, Volume: 32, Issue:5-6

    Topics: Arsenic; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Radioactivity; Radioisotopes; Skin Diseases

1951
[Radioactive arsenic in treatment of Hodgkin's disease and mycosis fungoides].
    Acta haematologica, 1952, Volume: 7, Issue:1

    Topics: Arsenic; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mycosis Fungoides; Radioisotopes

1952
[Value of arsenic therapy in mycosis fungoides].
    Archiv fur Dermatologie und Syphilis, 1951, Volume: 193, Issue:2

    Topics: Arsenic; Arsphenamine; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mycosis Fungoides

1951
[Experimental study on carcinogenicity of beryllium oxide and arsenic trioxide to the lung of rats by an intratracheal instillation (author's transl)].
    Fukuoka igaku zasshi = Hukuoka acta medica, 1980, Volume: 71, Issue:1

    Topics: Adenocarcinoma; Adenoma; Animals; Arsenic; Beryllium; Carcinogens; Carcinoma, Squamous Cell; Lung Neoplasms; Lymphoma; Male; Rats; Trachea

1980
Relative genotoxic potency of arsenic and its methylated metabolites.
    Mutation research, 1997, Volume: 386, Issue:3

    Topics: Animals; Arsenic; Chromosome Aberrations; Humans; Lymphoma; Methylation; Mice; Poisons; Tumor Cells, Cultured

1997
Inorganic arsenic--ambient level approach to the control of occupational cancerigenic exposures.
    Annals of the New York Academy of Sciences, 1976, Volume: 271

    Topics: Arsenic; Carcinogens, Environmental; Chemical Industry; Dose-Response Relationship, Drug; Environmental Health; Epidemiologic Methods; Humans; Lung Neoplasms; Lymphoma; Maximum Allowable Concentration; Occupational Diseases; Skin Neoplasms; United States

1976
Differential phosphate labeling of stress protein polypeptides in toxic dose response during S-phase of mouse lymphoma cells: a micro-electrophoretic study.
    Applied and theoretical electrophoresis : the official journal of the International Electrophoresis Society, 1989, Volume: 1, Issue:2

    Topics: Animals; Arsenic; Arsenites; Autoradiography; Biomarkers; Cell Nucleus; DNA; Electrophoresis, Polyacrylamide Gel; Heat-Shock Proteins; Hydrolysis; Lymphoma; Mice; Molecular Weight; Phosphorus Radioisotopes; Phosphorylation; S Phase; Sodium Compounds; Tumor Cells, Cultured

1989
Differential [32P]-labeling of chemically induced stress proteins in S-phase mouse lymphoma cells.
    Applied and theoretical electrophoresis : the official journal of the International Electrophoresis Society, 1989, Volume: 1, Issue:2

    Topics: Animals; Arsenic; Arsenites; Cell Nucleus; Concanavalin A; Electrophoresis, Gel, Two-Dimensional; Heat-Shock Proteins; Isoelectric Point; Isoproterenol; Liver; Lymphoma; Mice; Molecular Weight; Nuclear Proteins; Peptide Mapping; Phenobarbital; Phosphorus Radioisotopes; S Phase; Sodium Compounds; Spleen; Tumor Cells, Cultured

1989
Cell cycle-specific effects of sodium arsenite and hyperthermic exposure on incorporation of radioactive leucine and phosphate by stress proteins from mouse lymphoma cell nuclei.
    Biochimica et biophysica acta, 1987, Mar-11, Volume: 927, Issue:3

    Topics: Animals; Arsenic; Arsenites; Cell Line; Cell Nucleus; Heat-Shock Proteins; Hot Temperature; Leucine; Lymphoma; Mice; Molecular Weight; Phosphates; Phosphorus Radioisotopes; Sodium Compounds; Sulfhydryl Reagents; Tritium

1987
[Arsenic-induced leucoses in mice after diaplacental and postnatal application (author's transl)].
    Verhandlungen der Deutschen Gesellschaft fur Pathologie, 1971, Volume: 55

    Topics: Animals; Animals, Newborn; Arsenic; Female; Injections, Intravenous; Leukemia, Experimental; Leukemia, Lymphoid; Lymphoma; Maternal-Fetal Exchange; Mice; Pregnancy

1971